CDMRP Peer Reviewed Cancer Research Program: Translational Team Science Award

The Translational Team Science Award (TTSA) supports hypothesis-driven translational studies. Proposal should include 2-3 PIs (At least 1 military or VA investigator is encouraged to be included as an equal partner in the research) collaborating on one of the required FY22 RCRP topic Areas listed below:

• Bladder cancer
• Blood cancers
• Brain cancer
• Colorectal cancer
• Endometrial cancer
• Esophageal cancer
• Germ cell caners
• Head and neck cancers
• Liver cancer
• Lymphoma
• Mesothelioma
• Metastatic cancers
• Myeloma
• Neuroblastoma
• Pediatric, adolescent, and young adult cancers
• Pediatric brain tumors
• Stomach cancer
• Sarcoma
• Thyroid cancer
• New for FY22: Von Hippel-Lindau syndrome malignancies

Applications must also address at least one of the FY22 PRCRP Military Relevance Focus Areas:

• Environmental/exposure risk factors associated with cancer
• Gaps in cancer research that may affect mission readiness

It is expected that nine awards will be granted. 

Funding: $2,500,000 total
Duration: 4 years

Research Authority due date: 5.7.22

Pre application (required) due date: 12.7.22
Full application due date: 2.8.22